Greenwood Genetic Center

Similar documents
US Food and Drug Administration. Sandra L. Kweder, MD Deputy Director, Europe Office

A New Era of Clinical Diagnostics: How the Business Model is Changing.

Personalised Medicine Regulatory Issues

October 6, Below we provide input from our community of health informatics experts regarding select portions of the Draft Guidance.

The Curative and Transformative Potential of Novel Therapies for Rare Diseases in the Age of Precision Medicine

OPPORTUNITY PROFILE. Dean, Health & Public Safety

Annual Biomarkers Congress. Meetings International. September 20-21, 2018 Osaka, Japan. meetingsint.

The Power to Cure: Therapeutic Innovation in Academia

8/2/2017. Key attributes of scientific excellence: rigor, innovation, and relevance. Medical Physics 3.0. Key Attributes of Scientific Excellence

WKU Biotechnology Center Mission Statement and Bylaws

Community Health Initiative

Achieving Mayo s s Value Equation: The Role of Systems and Procedures

SSPPS STRATEGIC PLAN. Pharmacy Education, Pharmaceutical Sciences Research, Clinical Pharmacy Practice. April 30, Overview

Personalized. Health in Canada

The Biotechnology Program at Montgomery College

Senior Clinical Investigator

GUIDE HEA

EMBARGOED UNTIL 7:38 AM October 31, 2016

BIOTECHNOLOGY & LIFE SCIENCES

Territory Account Manager (MD, NC or TX based)

Eleventh Annual Chapel Hill Pharmaceutical Sciences Conference. Pharmacy in the Era of Precision Medicine: From Discovery to Implementation

Nordic Common Strengths and Future Potential in the Field of Personalised Medicine

American College Of Radiology Data Science Institute. Keith Dreyer DO, PhD, FACR Chief Science Officer ACR Data Science Institute May 30, 2018

Visit our Career Flowchart to get more information on some of these career paths.

to precision medicine

Genetic Research at Intermountain Healthcare. Marc S. Williams, MD, FAAP, FACMG Director, Clinical Genetics Institute Feb.

E&T objectives in evolving pharma business models. Magda Chlebus Director Science Policy Brussels, 2 March 2015

Lead the way. Molecular Imaging. GE Healthcare. imagination at work

Translational Medicine From Discovery to Health

TAIWAN. Who Should Attend? Endless Potential & Opportunities. Where innovations are shaping a new era of intelligent healthcare.

The Global Coalition for Regulatory Science Research (GCRSR)

PS02 Biomarker Analysis. Discussant. Sue-Jane Wang, Ph.D.

Is a Career in the. Pharmaceutical. Check out our online Student Center to find out more:

SWES 2021 STRATEGIC PLAN

Introduction to Genomic Medicine Using Galaxy Platform (Workshop)

Careers in Biotech: My Start at Abeona Therapeutics

Building Leadership Capability in Times of Transition and Change

GREENPRINT TO BREAKTHROUGH RESEARCH

Human Genomics, Precision Medicine, and Advancing Human Health. The Human Genome. The Origin of Genomics : 1987

Precision Medicine. Presented by:

A LEADER IN SPECIALTY CARE

Growing the Future. Department of Crop Science Strategic Plan

Success Factors in Creating Science- Based Business. Saskia Biskup, Tuebingen, Germany

Centre for NanoHealth

FREQUENTLY ASKED QUESTIONS

ORACLE OTTAWA REGION FOR ADVANCED CARDIOVASCULAR RESEARCH EXCELLENCE STRATEGIC DIRECTIONS

BIOTECHNOLOGY & LIFE SCIENCES

Next Generation Molecular Diagnostics in Scotland. Dr Mark Drummond Haematologist, Beatson Cancer Centre

Oversight of Laboratory Developed Tests

Production Assistance for Cellular Therapies PACT

Molecular Diagnostics

Laced. Legacy. Living. the. Mission. Strategic Plan Summary 2018

Washington State University NOTICE OF VACANCY. Position # TITLE: Assistant/Associate Professor Soil Nutrient and Residue Management

Re: Docket No. 2006D-0347, Federal Register: July 26, 2007 (Volume 72, Pages )

DUHS Revenue Cycle Management & Clinical Integration Program

Biology Registration Newsletter for Fall 2018 Courses

Biopeople at a Glance

FDA Driving Biomedical Product Innovation

Genomics in the NHS. Professor Sue Chief Scientific Officer for England

STRAND NGS 3.0 ALLOWS USERS TO ANALYZE DATA AT NEARLY TWICE THE SPEED

A.D. Medical Science Liaisons Allergy/Food Allergy/Immunology (Eastern US) Sr. Director, Global Head MSLs

Rare Diseases: Challenges and Opportunities NIH Perspective

THREE -YEAR STRATEGIC PLAN

SYLLABUS. Departmental Syllabus. Introduction to Biotechnology. Departmental Syllabus. Departmental Syllabus. Departmental Syllabus

MARCH 15-16, 2018 PARIS PALAIS BRONGNIART. An event of PROGRAM

CCTG initiative. patient reported outcomes (including wearables)

Our job today Enlist you to help us cross the Translational Divide between the lab bench and the patient s bedside Demonstrate that this will

2018/2019 final draft National Genomic Test Directory FAQ

PD, CC&E, & Planning. Created Tuesday, September 25, 2012 By Kale Braden

Improve Patient Satisfaction Through Employee Rounding. Tracking & Improving Employee Satisfaction Scores

UC Davis Collaborative for Diagnostic Innovation. Lydia P. Howell MD Professor and Chair, Pathology & Laboratory Medicine

Molecular Diagnostics Regulation Shifting from a Biomarker-Based Approach to an Algorithm-Based Approach

Regulatory and Reimbursement Obstacles Clinical Update of Molecular Diagnostics ASU

Democratized Data Driving Discovery RENCI Strategic Plan 2017

Mentoring/Faculty Development Plan MUSC - Department of Obstetrics and Gynecology

The European Medicines Agency: A well-established Agency of the EU protecting human and animal health for all EU citizens

UC Davis Collaborative for Diagnostic Innovation. Lydia P. Howell MD Professor and Chair, Pathology & Laboratory Medicine

Jefferies 2014 Global Healthcare Conference June 3, 2014 NYSE: Q

New Paradigms in Drug Discovery: How Genomic Data are Being Used to Revolutionize the Drug Discovery and Development Process A Workshop

395 South Youngs Road Buffalo, New York cognigencorp.com An On-Site 2-Day Workshop in Engineering The Pharmacometric Enterprise

Development of a Dual University System Health Research Partnership as a Foundation for the Sustainable Development Goals

Precision Medicine: Harnessing Biomedical Data to Improve the Prediction, Prevention, Diagnosis and Treatment of Disease

Issues in Cancer Drug Development of the Future. Janet Woodcock M.D. Deputy Commissioner/Chief Medical Officer, FDA October 5, 2007

Interview. Maximizing the Value of Biospecimens to Deliver New Therapies. with Clive Green, PhD, Director and Head of Sample Management at AstraZeneca

Associate Group Medical Director - MD

Precision Medicine Catapult

SMEs in IMI2 Calls for Proposals

Prior to 2014, the mission of the Consortium of MS Centers was:

PAREXEL GENOMIC MEDICINE SERVICES. Applying genomics to enhance your drug development journey

Genomic Medicine for the University of Vermont Health Network

TOTAL CANCER CARE: CREATING PARTNERSHIPS TO ADDRESS PATIENT NEEDS

IMEDS: Sentinel and OMOP Programs Jane Reese-Coulbourne, MS, ChE Executive Director Reagan-Udall Foundation for the FDA

WHILE A SMALL NUMBER OF PEOPLE ARE SUFFERING FROM A SINGLE RARE DISEASE, 350 MILLION PEOPLE WORLDWIDE ARE SUFFERING FROM RARE DISEASES.

Facilitating the Use of Imaging Biomarkers in Therapeutic Clinical Trials. Michael Graham, PhD, MD President, SNM Co-chair, Clinical Trials Network

Focus on Health Research

Vanderbilt s Transformation Journey

EXECUTIVE SUMMARY. Overview of Autoimmune Disease Research

THE IMPACT OF THE AFFORDABLE CARE ACT (ACA) ON CANCER RESEARCH, CARE, AND PREVENTION

Statements on the Regulation of Laboratory Developed Tests

Why Culture Matters in Cancer Research

Transcription:

Greenwood Genetic Center: The Center for Human Genetics and The Partnership Campus A Growing Collaborative South Carolina Community Development Association Steve Skinner, M.D. Greenwood Genetic Center www.ggc.org State Wide Reach SC Community Development Association 1

Greenwood Genetic Center Founded in 1974 by the SC Department of Disabilities and Special Needs (DDSN) and the Self Family Foundation as a not for profit genetic institute. Mission: provide clinical genetic services and diagnostic testing develop educational programs and materials conduct research in the field of medical genetics Greenwood Genetic Center Faculty & Staff: 34 geneticists/research scientists 23 genetic counselors/caseworkers 6 fellows/residents 54 technologists 58 support personnel Budget: Approximately $22 million per year Clemson University Center for Human Genetics SC Community Development Association 2

Clemson University Center for Human Genetics 17,000 sq. ft. labs, classrooms, offices Five new faculty hires Self Family Endowed Chair 15 graduate students Research collaboration Self Regional Healthcare: Lead Clinical Research Hospital in the Center for Human Genetics Capital commitment $2,000,000 Research commitment $1,200,000/year x 3 6 research grants funded in 2014 5 in autism 1 in oncology test development Genomic Growth NGS revenue in U.S. in 2014: $910 M NGS projected revenue in U.S. in 2020: $6 B On per capita basis, project $15.7 M in NGS in S.C. in 2015: $1.7 M of NGS done at GGC Did $14 M of NGS go out of state? Could we capture all NGS in S.C.? SC Community Development Association 3

Genomic Competition Florida in 2002: $310 M to develop Scripps Research Institute Alabama in 2005: $50 M to develop HudsonAlpha Institute for Biotechnology Texas in 2005: $50 M to develop Texas A&M Institute for Genomic Medicine Arizona in 2002: $30 M plus a building to develop Translational Genomics Research Institute South Carolina Opportunities Genomic Computational Center Genomic Sequencing Center Genomic Technology Innovation Center Undiagnosed Disease Program Novel Genomic Therapies Center Autism Research and Treatment Center of Excellence GGC Community Map Lander University GGC Uptown Greenwood Self Medical Center Medical Innovation District SC Community Development Association 4

GGC Full Build Out Plan 3 Partnership North Clemson Center for Human Genetics 1 GGC Heritage 29.81 acres 2 2 Clemson Center 12.86 acres 1 3 Partnership North 40.76 acres GGC Heritage Campus 4 Partnership South 42.25 acres 4 Partnership South Point A Consulting Greenwood Research Park Strategic Plan Land Plan Workshop Key Premises ACTIVATING GGC S PARTNERSHIP CAMPUS DEVELOPMENT OPPORTUNITIES During this initial phase, GGC is expected to be largely passive Critical to focus on implementing Sustainability Study recommendations GGC will partner with GPA, who will take the active leadership role Importance of establishing the framework for such a partnership, sharing of roles and responsibilities. Key Sustainability Themes Identified from Interviews and Initial Analysis Three broad themes for GGC s sustainability were identified: Modernization of operations reflecting the need for greater efficiency of existing resources, while also creating the capacity to grow. Diversification of revenue sources tapping a broader range of funding sources to support the ongoing operations of GGC. Pursuit of growth initiatives fulfilling the mission of GGC with an enhancement of its activities so that it can have even greater impact in the years ahead. 15 SC Community Development Association 5

The Era of Genomics in Patient Care Clinical Target Basic Research Precision Medicine Patient Therapeutic Development FDA & Regulatory SC Community Development Association 6